Adaptive Biotechnologies Corp Annual Depreciation in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Adaptive Biotechnologies Corp quarterly/annual Depreciation history and growth rate from 2017 to 2023.
  • Adaptive Biotechnologies Corp Depreciation for the quarter ending March 31, 2024 was $4.79M, a 4.26% decline year-over-year.
  • Adaptive Biotechnologies Corp annual Depreciation for 2023 was $20.5M, a 6.82% increase from 2022.
  • Adaptive Biotechnologies Corp annual Depreciation for 2022 was $19.2M, a 56.9% increase from 2021.
  • Adaptive Biotechnologies Corp annual Depreciation for 2021 was $12.3M, a 81% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $20.5M +$1.31M +6.82% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $19.2M +$6.97M +56.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $12.3M +$5.49M +81% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $6.77M +$676K +11.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-14
2019 $6.09M +$1.79M +41.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $4.3M +$199K +4.85% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $4.1M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.